Compounds > clopidogrel

clopidogrel and Ovarian Neoplasms

clopidogrel has been researched along with Ovarian Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alosh, M; Huque, MF; Koch, GG1
Backman, J; Bergmann, TK; Brosen, K; Filppula, AM; Launiainen, T; Nielsen, F1
Broderick, TM; Dalia, AA; Essandoh, MK; Flores, AS; George, BS; Kirtane, AJ; Otey, AJ; Rao, SV1

Other Studies

3 other study(ies) available for clopidogrel and Ovarian Neoplasms

ArticleYear
Statistical Perspectives on Subgroup Analysis: Testing for Heterogeneity and Evaluating Error Rate for the Complementary Subgroup.
    Journal of biopharmaceutical statistics, 2015, Volume: 25, Issue:6

    Topics: Algorithms; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspirin; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Clopidogrel; Doxorubicin; Female; Humans; Ischemia; Ovarian Neoplasms; Platelet Aggregation Inhibitors; Reproducibility of Results; Research Design; Sample Size; Ticlopidine; Topotecan

2015
Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma.
    British journal of clinical pharmacology, 2016, Volume: 81, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inhibitors; Drug Interactions; Female; Humans; Middle Aged; Neurotoxicity Syndromes; Ovarian Neoplasms; Paclitaxel; Ticlopidine

2016
CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?
    Journal of cardiothoracic and vascular anesthesia, 2016, Volume: 30, Issue:6

    Topics: Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Metoprolol; Middle Aged; Morphine; Myocardial Infarction; Nitroglycerin; Ovarian Neoplasms; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Retreatment; Ticlopidine; Treatment Outcome; Vasodilator Agents

2016